Platelets modulate vascular system integrity, and their loss is critical in haematological pathologies and after chemotherapy. Therefore, identification of molecules enhancing platelet production would be useful to counteract thrombocytopenia. We have previously shown that 2-arachidonoylglycerol (2-AG) acts as a true agonist of platelets, as well as it commits erythroid precursors toward the megakaryocytic lineage. Against this background, we sought to further interrogate the role of 2-AG in megakaryocyte/platelet physiology by investigating terminal differentiation, and subsequent thrombopoiesis. To this end, we used MEG-01 cells, a human megakaryoblastic cell line able to produce in vitro platelet-like particles.

2-AG increased the number of cells showing ruffled surface and enhanced surface expression of specific megakaryocyte/platelet surface antigens, typical hallmarks of terminal megakaryocytic differentiation and platelet production. Changes in cytoskeleton modeling also occurred in differentiated megakaryocytes and blebbing platelets. 2-AG acted by binding to CB₁ and CB₂ receptors, because specific antagonists reverted its effect. Platelets were split off from megakaryocytes and were functional: they contained the platelet-specific surface markers CD61 and CD49, whose levels increased following stimulation with a natural agonist like collagen. Given the importance of 2-AG for driving megakaryopoiesis and thrombopoiesis, not surprisingly we found that its hydrolytic enzymes were tightly controlled by classical inducers of megakaryocyte differentiation.

In conclusion 2-AG, by triggering megakaryocyte maturation and platelet release, may have clinical efficacy to counteract thrombocytopenia-related diseases.

Keywords: cluster of differentiation, cytoskeleton, Differentiation, endocannabinoid system, haematopoietic cells, megakaryocytes, platelets

Abstract

References

1. Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost 2005; 31:381-92; PMID:16149014 [[PubMed]
2. Wagner DD, Burger PC. Platelets in Inflammation and Thrombosis. Arterioscler Thromb Vasc Biol 2003; 23:2131-7; PMID:14500287 [[PubMed]
3. Vindrieux D, Gras B, Garcia-Belinchon M, Mourah S, Lebbe C, Augert A, Bernard D. Platelet-derived growth factor B induces senescence and transformation in normal human fibroblasts. Aging 2013; 5:531-8; PMID:23934686
4. Coleman PR, Chang G, Hutas G, Grimshaw M, Vadas MA, Gamble JR. Age-associated stresses induce an anti-inflammatory senescent phenotype in endothelial cells. Aging 2013; 5:913-24; PMID:24334613
5. Feng X, Scheinberg P, Samsel L, Rios O, Chen J, McCoy JPJr, Ghanima W, Bussel JB, Young NS. Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura. J Thromb Haemost 2012; 10:1616-23; PMID:22537155; 10.1111/j.1538-7836.2012.04757.x ] [[Google Scholar]
6. Kwaan HC, Huyck T. Thromboembolic and bleeding complications in acute leukemia. Expert Rev Hematol 2010; 3:719-30; PMID:21091148 [[PubMed]
7. Lieu YK, Reddy EP. Impaired adult myeloid progenitor CMP and GMP cell function in conditional c-myb-knockout mice. Cell Cycle 2012; 11:3504-12; PMID:22918254
8. Amodio N, Bellizzi D, Leotta M, Raimondi L, Biamonte L, D'Aquila P, Di Martino MT, Calimeri T, Rossi M, Lionetti M, et al miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cellsCell Cycle 2013; 12:3650-62; PMID:24091729 [Google Scholar]
9. Walters DK, Arendt BK, Jelinek DF. CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells. Cell Cycle 2013; 12:3175-83; PMID:24013424
10. John K, Wielgosz S, Schulze-Osthoff K, Bantel H, Hass R. Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndrome. Cell Death Dis 2013; 4:e886; PMID:24157880
11. Harper MT, Poole AW. Chloride channels are necessary for full platelet phosphatidylserine exposure and procoagulant activity. Cell Death Dis 2013; 4: e969; PMID:24357800
12. Kmit A, van Kruchten R, Ousingsawat J, Mattheij NJ, Senden-Gijsbers B, Heemskerk JW, Schreiber R, Bevers EM, Kunzelmann K. Calcium-activated and apoptotic phospholipid scrambling induced by Ano6 can occur independently of Ano6 ion currents. Cell Death Dis 2013; 4:e611; PMID:23618909
13. Baldo BA, Pham NH. Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch. Cancer Metastasis Rev 2013; 32:723-61; PMID:24043487; 10.1007/s10555-013-9447-3 [] [
14. Chen W, Wu Q, Mo L, Nassi M. Intra-arterial chemotherapy is not superior to intravenous chemotherapy for malignant gliomas: a systematic review and meta-analysis. Eur Neurol 2013; 70:124-32; PMID:23859844 [[PubMed]
15. Dy GK, Adjei AA. Understanding, recognizing, and managing toxicities of targeted anticancer therapies. CA Cancer J Clin 2013; 63:249-79; PMID:23716430; 10.3322/caac.21184 [] [[PubMed]
16. de Graaf CA, Metcalf D. Thrombopoietin and hematopoietic stem cells. Cell Cycle 2011; 10:1582-9; PMID:21478671
17. Demeter J, Istenes I, Fodor A, Paksi M, Dombi P, Valasinyószki E, Csomor J, Matolcsy A, Nagy ZG. Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma. Pathol Oncol Res 2011; 17:141-3; PMID:20628840; 10.1007/s12253-010-9276-4 [] [
18. Thiagarajan P, Afshar-Kharghan V. Platelet transfusion therapy. Hematol Oncol Clin North Am 2013; 27:629-43; PMID:23714315; 10.1016/j.hoc.2013.03.004 [] [
19. Wu S, Zhang Y, Xu L, Dai Y, Teng Y, Ma S, Ho SH, Kim JM, Yu SS, Kim S, et al Multicenter, randomized study of genetically modified recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in cancer patients receiving chemotherapy. Support Care Cancer 2012; 20:1875-84; PMID:22041866; 10.1007/s00520-011-1290-x [] [[Google Scholar]
20. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, et al Identification and functional characterization of brain stem cannabinoid CB2 receptors. Science 2005; 310:329-32; PMID:16224028 [[PubMed][Google Scholar]
21. Egertova M, Cravatt BF, Elphick MR. Comparative analysis of fatty acid amide hydrolase and CB1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signalling. Neuroscience 2003; 119:481-96; PMID:12770562 [[PubMed]
22. Dando I, Donadelli M, Costanzo C, Dalla Pozza E, D'Alessandro A, Zolla L, Palmieri M. Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells. Cell Death Dis 2013; 4:e664; PMID:23764845; 10.1038/cddis.2013.151 ] [
23. Rimmerman N, Ben-Hail D, Porat Z, Juknat A, Kozela E, Daniels MP, Connelly PS, Leishman E, Bradshaw HB, Shoshan-Barmatz V, et al Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death, Cell Death Dis 2013; 4:e949; PMID:24309936; 10.1038/cddis.2013.471 ] [[Google Scholar]
24. Vara D, Morell C, Rodríguez-Henche N, Diaz-Laviada I. Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma. Cell Death Dis 2013; 4:e618; PMID:23640460; 10.1038/cddis.2013.141 ] [
25. Mecha M, Torrao AS, Mestre L, Carrillo-Salinas FJ, Mechoulam R, Guaza C. Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress. Cell Death Dis 2012; 3:e331; PMID:22739983; 10.1038/cddis.2012.71 ] [
26. Maccarrone M, Del Principe D, Finazzi Agrò A. Endocannabinoids: New physiological (co-) agonists of human platelets. Thromb Haemost 2002; 88:165-6; PMID:12152663 [[PubMed]
27. Catani MV, Gasperi V, Evangelista D, Finazzi Agrò A, Avigliano L, Maccarrone M. Anandamide extends platelets survival through CB(1)-dependent Akt signalling. Cell Mol Life Sci 2010; 67:601-10; PMID:19936621; 10.1007/s00018-009-0198-9 [] [
28. Malorni W, Bari M, Straface E, Battista N, Matarrese P, Finazzi-Agrò A, Del Principe D, Maccarrone M. Morphological evidence that 2-arachidonoylglycerol is a true agonist of human platelets. Thromb Haemost 2004; 92:1159-61; PMID:15543349 [[PubMed]
29. Catani MV, Fezza F, Baldassarri S, Gasperi V, Bertoni A, Pasquariello N, Finazzi-Agrò A, Sinigaglia F, Avigliano L, Maccarrone M. Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol. J Mol Med 2009; 87:65-74; PMID:18820887; 10.1007/s00109-008-0406-3 [] [
30. O'Brien JJ, Spinelli SL, Tober J, Blumberg N, Francis CW, Taubman MB, Palis J, Seweryniak KE, Gertz JM, Phipps RP. 15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes. Blood 2008; 112:4051-60; PMID:18755987; 10.1182/blood-2008-05-158535 ] [
31. Takeuchi K, Satoh M, Kuno H, Yoshida T, Kondo H, Takeuchi M. Platelet-like particle formation in the human megakaryoblastic leukaemia cell lines, MEG-01 and MEG-01s. Br J Haematol 1998; 100:436-44; PMID:9488640 [[PubMed]
32. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavón FJ, Serrano AM, Selley DE, Parsons LH, et al Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 2009; 5:37-44; PMID:19029917; 10.1038/nchembio.129 ] [[Google Scholar]
33. Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, et al International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev 2010; 62:588-631; PMID:21079038; 10.1124/pr.110.003004 ] [[Google Scholar]
34. Hillard CJ, Manna S, Greenberg MJ, DiCamelli R, Ross RA, Stevenson LA, Murphy V, Pertwee RG, Campbell WB. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther 1999; 289:1427-33; PMID:10336536 [[PubMed]
35. Griffin G, Fernando SR, Ross RA, McKay NG, Ashford ML, Shire D, Huffman JW, Yu S, Lainton JA, Pertwee RG. Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur J Pharmacol 1997; 339:53-61; PMID:9450616 [[PubMed]
36. Italiano JE, Jr, Lecine P, Shivdasani RA, Hartwig JH. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 1999; 147:1299-312; PMID:10601342
37. Machlus KR, Italiano JE. The incredible journey: From megakaryocyte development to platelet formation. J Cell Biol 2013; 201:785-96; PMID:23751492; 10.1083/jcb.201304054 ] [
38. Breton-Gorius J, Vainchenker W. Expression of platelet proteins during the in vitro and in vivo differentiation of megakaryocytes and morphological aspects of their maturation. Sem Hematol 1986; 23:43-67; PMID:3003921 [[PubMed]
39. Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood 2003; 102:449-61; PMID:12649139 [[PubMed]
40. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest 1986; 78:130-7; PMID:2941452
41. Gasperi V, Evangelista D, Chiurchiù V, Florenzano F, Savini I, Oddi S, Avigliano L, Catani MV, Maccarrone M. 2-Arachidonoylglycerol modulates human endothelial cell/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptors. Int J Biochem Cell Biol 2014; 51:79-88; 10.1016/j.biocel.2014.03.028 [] [
42. Catani MV, Gasperi V, Catanzaro G, Baldassarri S, Bertoni A, Sinigaglia F, Avigliano L, Maccarrone M. Human platelets express authentic CB₁ and CB₂ receptors. Curr Neurovasc Res 2010; 7:311-8; PMID:20854251 [[PubMed]
43. Abd-Elrahman I, Deutsch V, Pick M, Kay S, Neuman T, Perlman R, Ben-Yehuda D. Differential regulation of the apoptotic machinery during megakaryocyte differentiation and platelet production by inhibitor of apoptosis protein Livin. Cell Death Dis 2013; 4:e937; PMID:24287698; 10.1038/cddis.2013.454 ] [
44. Chen S, Su Y, Wang J. ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation. Cell Death Dis 2013; 4:e722; PMID:23846224; 10.1038/cddis.2013.253 ] [
45. Lordier L, Pan J, Naim V, Jalil A, Badirou I, Rameau P, Larghero J, Debili N, Rosselli F, Vainchenker W, et al Presence of a defect in karyokinesis during megakaryocyte endomitosis. Cell Cycle 2012; 11:4385-9; PMID:23159853; 10.4161/cc.22712 ] [[Google Scholar]
46. Rukoyatkina N, Mindukshev I, Walter U, Gambaryan S. Dual role of the p38 MAPK/cPLA2 pathway in the regulation of platelet apoptosis induced by ABT-737 and strong platelet agonists. Cell Death Dis 2013; 4:e931; PMID:24263105; 10.1038/cddis.2013.459 ] [
47. Kodama T, Hikita H, Kawaguchi T, Shigekawa M, Shimizu S, Hayashi Y, Li W, Miyagi T, Hosui A, Tatsumi T, et al Mcl-1 and Bcl-xL regulate Bak/Bax-dependent apoptosis of the megakaryocytic lineage at multistages. Cell Death Differ 2012; 19:1856-69; PMID:22790873; 10.1038/cdd.2012.88 ] [[Google Scholar]
48. Fernández-Morales B, Pavón L, Calés C. CDC6 expression is regulated by lineage-specific transcription factor GATA1. Cell Cycle 2012; 11:3055-66; PMID:22871742; 10.4161/cc.21471 ] [
49. Besancenot R, Roos-Weil D, Tonetti C, Abdelouahab H, Lacout C, Pasquier F, Willekens C, Rameau P, Lecluse Y, Micol JB, et al JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation versus differentiation. Blood 2014. pii: blood-2014-03-559815; PMID:25143485; 10.1182/blood-2014-03-559815 ] [[Google Scholar]
50. Smith BW, Murphy GJ. Stem cells, megakaryocytes, and platelets. Curr Opin Hematol 2014; 21:430-7; PMID:25023469; 10.1097/MOH.0000000000000064 ] [
51. Patinkin D, Milman G, Breuer A, Fride E, Mechoulam R. Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation. Eur J Pharmacol 2008; 595:1-6; PMID:18778813; 10.1016/j.ejphar.2008.05.002 [] [
52. Jiang S, Fu Y, Avraham HK. Regulation of hematopoietic stem cell trafficking and mobilization by the endocannabinoid system. Transfusion 2011; 51: 65S-71S; PMID:22074629; 10.1111/j.1537-2995.2011.03368.x [] [
53. Jiang S, Alberich-Jorda M, Zagozdzon R, Parmar K, Fu Y, Mauch P, Banu N, Makriyannis A, Tenen DG, Avraham S, et al Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. Blood 2011; 117:827-38; PMID:21063029; 10.1182/blood-2010-01-265082 ] [[Google Scholar]
54. Galve-Roperh I, Chiurchiù V, Díaz-Alonso J, Bari M, Guzmán M, Maccarrone M. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. Prog Lipid Res 2013; 52:633-50; PMID:24076098; 10.1016/j.plipres.2013.05.004 [] [
55. Au AE, Sashindranath M, Borg RJ, Kleifeld O, Andrews RK, Gardiner EE, Medcalf RL, Samson AL. Activated platelets rescue apoptotic cells via paracrine activation of EGFR and DNA-dependent protein kinase. Cell Death Dis 2014; 5: e1410; PMID:25210793; 10.1038/cddis.2014.373 ] [
56. Valdeolivas S, Pazos MR, Bisogno T, Piscitelli F, Iannotti FA, Allarà M, Sagredo O, Di Marzo V, Fernández-Ruiz J. The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG. Cell Death Dis 2013; 4:e862; PMID:24136226; 10.1038/cddis.2013.387 ] [
57. Samokhvalov V, Alsaleh N, El-Sikhry HE, Jamieson KL, Chen CB, Lopaschuk DG, Carter C, Light PE, Manne R, Falck JR, et al Epoxyeicosatrienoic acids protect cardiac cells during starvation by modulating an autophagic response. Cell Death Dis 2013; 4:e885; PMID:24157879; 10.1038/cddis.2013.418 ] [[Google Scholar]
58. Mohebali D, Kaplan D, Carlisle M, Supiano MA, Rondina MT. Alterations in platelet function during aging: clinical correlations with thromboinflammatory disease in older adults. J Am Geriatr Soc 2014; 62:529-35; PMID:24512275; 10.1111/jgs.12700 ] [
59. Dovizio M, Alberti S, Guillem-Llobat P, Patrignani P. Role of platelets in inflammation and cancer: novel therapeutic strategies. Basic Clin Pharmacol Toxicol 2014; 114:118-27; PMID:24118902; 10.1111/bcpt.12156 [] [
60. Maynard S, Keijzers G, Gram M, Desler C, Bendix L, Budtz-Jørgensen E, Molbo D, Croteau DL, Osler M, Stevnsner T, et al Relationships between human vitality and mitochondrial respiratory parameters, reactive oxygen species production and dNTP levels in peripheral blood mononuclear cells. Aging 2013; 5:850-64; PMID:24304678 [Google Scholar]
61. Shafique E, Choy WC, Liu Y, Feng J, Cordeiro B, Lyra A, Arafah M, Yassin-Kassab A, Zanetti AV, Clements RT, et al Oxidative stress improves coronary endothelial function through activation of the pro-survival kinase AMPK. Aging 2013; 5:515-30; PMID:24018842 [Google Scholar]
62. Dayal S, Wilson KM, Motto DG, Miller FJJr, Chauhan AK, Lentz SR. Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis. Circulation 2013; 127:1308-16; PMID:23426106; 10.1161/CIRCULATIONAHA.112.000966 ] [[Google Scholar]
63. Tang Q, Koh LK, Jiang D, Schwarz H. CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging. Aging 2013; 5:643-52; PMID:23945137
64. Gautam S, Kirschnek S, Gentle IE, Kopiniok C, Henneke P, Häcker H, Malleret L, Belaaouaj A, Häcker G. Survival and differentiation defects contribute to neutropenia in glucose-6-phosphatase-β (G6PC3) deficiency in a model of mouse neutrophil granulocyte differentiation. Cell Death Differ 2013; 20:1068-79; PMID:23686134; 10.1038/cdd.2013.39 ] [
65. Vasina EM, Cauwenberghs S, Staudt M, Feijge MA, Weber C, Koenen RR, Heemskerk JW. Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release. Am J Blood Res 2013; 3:107-23; PMID:23675563
66. Peche LY, Scolz M, Ladelfa MF, Monte M, Schneider C. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs. Cell Death Differ 2012; 19:926-36; PMID:22117195; 10.1038/cdd.2011.173 ] [
67. Mezouar S, Mege D, Darbousset R, Farge D, Debourdeau P, Dignat-George F, Panicot-Dubois L, Dubois C. Involvement of platelet-derived microparticles in tumor progression and thrombosis. Semin Oncol 2014; 41:346-58; PMID:25023350; 10.1053/j.seminoncol.2014.04.010 [] [
68. Antonov AV, Knight RA, Melino G, Barlev NA, Tsvetkov PO. MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets. Cell Death Differ 2013; 20:367; PMID:23175189; 10.1038/cdd.2012.137 ] [
69. Ogura M, Morishima Y, Okumura M, Hotta T, Takamoto S, Ohno R, Hirabayashi N, Nagura H, Saito H. Functional and morphological differentiation induction of a human megakaryoblastic leukemia cell line (MEG-01) by phorbol diesters. Blood 1988; 72:49-60; PMID:2455575 [[PubMed]
70. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, et al Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid knockout in the brain. J Cell Biol 2003; 163:463-8; PMID:14610053 [Google Scholar]
71. Gasperi V, Ceci R, Tantimonaco M, Talamonti E, Battista N, Parisi A, Florio R, Sabatini S, Rossi A, Maccarrone M. The fatty acid amide hydrolase in lymphocytes from sedentary and active subjects. Med Sci Sports Exerc 2014; 46:24-32; PMID:23793235; 10.1249/MSS.0b013e3182a10ce6 [] [
72. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 2002; 99:10819-24; PMID:12136125
73. Savini I, Arnone R, Catani MV, Avigliano L. Origanum vulgare induces apoptosis in human colon cancer caco2 cells. Nutr Cancer 2009; 61:381-9; PMID:19373612; 10.1080/01635580802582769 [] [